Quantbot Technologies’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Quantbot Technologies’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,900	Closed	-$75.2K	–	2088
2023 Q1	$75.2K	Buy	+17,900	New	+$92.9K	0.01%	1164

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Quantbot Technologies's CTIC Position: Q2 2023 in Review

Quantbot Technologies sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 17,900 shares — an estimated $75.2K sold.

Quantbot Technologies first reported a position in CTIC in Q1 2023 and held it in 1 quarter. The position peaked at $75.2K in Q1 2023. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Quantbot Technologies reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Quantbot Technologies sold 17,900 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $75.2K.
Quantbot Technologies first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2023 and held it in 1 quarter.
Quantbot Technologies's CTI BioPharma Corp. (DE) Common Stock position peaked at $75.2K in Q1 2023.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Quantbot Technologies's 13F filing for Q2 2023, filed 8 Aug 2023.